Patent details

91119 Product Name: Bivalirudine et ses dérivés pharmaceutiquement acceptables (ANGIOX®)

Basic Information

Publication number:
91119
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP909127540
Legal Status:
Expired
Application number:
91119
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/04/289/001
Marketing Authorization Type:
Marketing Authorization Date:
20/09/2004
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
29/10/2004
First Marketing Authorization date:
20/09/2004
Grant date:
29/12/2004
Activation date:
17/08/2010
Publication date:
29/12/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
17/08/2015
SPC Extension Expiration:
17/08/2015
Rejection date:
Withdrawal date:

Owner

From:
22/03/2006
 
 

Name:
BIOGEN IDEC MA INC.
Address:
CAMBRIDGE CENTER 14, CAMBRIDGE, MA 02142, United States (US)

From:
29/10/2004
 
 

Name:
HEALTH RESEARCH INCORPORATED
Address:
66 Hackett Boulevard, 3rd Floo, Albany NY 12209, United States (US)

History of Owners

From:
29/10/2004
To:
21/03/2006

Name:
BIOGEN INC.
Address:
CAMBRIDGE CENTER 14, 02142, CAMBRIDGE MASSACHUSETTS, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/10/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KLINE Toni
Address:
United States (US)

2

Name:
MARAGANORE John, M.
Address:
United States (US)

3

Name:
FENTON John, W., II
Address:
United States (US)
Filing date Document type Number of pages